BioCardia to present CardiAMP updates at H.C. Wainwright
BioCardia said it will present CardiAMP regulatory progress, the ongoing CardiAMP HF II pivotal trial and Helix and Heart3D platform updates at the H.C. Wainwright conference.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
BioCardia said it will present CardiAMP regulatory progress, the ongoing CardiAMP HF II pivotal trial and Helix and Heart3D platform updates at the H.C. Wainwright conference.